Drawing for ELEVATEBIO BASECAMP

USPTO serial 88465392

ELEVATEBIO BASECAMP

Reviewed by CopyMark Law Group

Reg. 6815464Status 700Registered
Filing date
Status date
Registration date
Aug 9, 2022
Examiner
REAMS, CHRISTOPHER THOMAS
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ELEVATEBIO BASECAMP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 BENSON DRRALEIGH, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research services; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of medicines; Research and development services in the field of antibodies; Research, development, engineering and testing services in the fields of immunopharmaceuticals; Biochemical research and development; Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment; Medical research services in the field of cancer; Pharmaceutical research and development; Product research and development; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical testing services and information in the field of cancer research and disease classification; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapyACTIVEJul 25, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 9, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 9, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 8, 2022SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 7, 2022CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 31, 2022SUPCSTATEMENT OF USE PROCESSING COMPLETE
May 26, 2022IUAFUSE AMENDMENT FILED
May 26, 2022EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 4, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 2, 2021EX4GSOU EXTENSION 4 GRANTED
Dec 2, 2021EXT4SOU EXTENSION 4 FILED
Dec 2, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 9, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 8, 2021EX3GSOU EXTENSION 3 GRANTED
Jul 7, 2021NREVNOTICE OF REVIVAL - E-MAILED
Jul 6, 2021TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION
Jul 6, 2021PETGPETITION TO REVIVE-GRANTED
Jul 6, 2021PROATEAS PETITION TO REVIVE RECEIVED
Jul 6, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 5, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 10, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 10, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 10, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 3, 2021EXT3SOU EXTENSION 3 FILED
Jan 14, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 13, 2021EX2GSOU EXTENSION 2 GRANTED
Jan 5, 2021NREVNOTICE OF REVIVAL - E-MAILED
Jan 4, 2021TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION
Jan 4, 2021PETGPETITION TO REVIVE-GRANTED
Jan 4, 2021PROATEAS PETITION TO REVIVE RECEIVED
Jan 4, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 4, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 3, 2020EXT2SOU EXTENSION 2 FILED
Aug 22, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 21, 2020EX1GSOU EXTENSION 1 GRANTED
Aug 20, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 7, 2020NREVNOTICE OF REVIVAL - E-MAILED
Jul 6, 2020TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION
Jul 6, 2020PETGPETITION TO REVIVE-GRANTED
Jul 6, 2020PROATEAS PETITION TO REVIVE RECEIVED
Jul 6, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 6, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 3, 2020EXT1SOU EXTENSION 1 FILED
Dec 3, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 8, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 8, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 18, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 31, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 29, 2019DOCKASSIGNED TO EXAMINER
Jun 21, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 12, 2019NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance